GlassScriptPhysician profile
Robert Mousselli
NPI 1811309016
$33,563.46
in general payments reported to CMS, 2019-2025
22 companies · $4,328 in 2025
The $4,328 reported for 2025 was more than what 93% of Pain Medicine (Physical Medicine & Rehabilitation) providers received nationally (typical 2025 total: $400).
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $22K · 2024: $7,073 · 2025: $4,328.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $19K · Food and Beverage: $9,152 · Travel and Lodging: $5,320.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $19,091.00 |
| Food and Beverage | $9,152.42 |
| Travel and Lodging | $5,320.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $16,659.53 | 2023-2025 | Synchromedii, Intellis Adaptivestim, Vanta Adaptivestim |
| Abbott Laboratories | $9,388.97 | 2023-2024 | Eterna, Proclaim |
| Spinal Simplicity, LLC | $3,478.04 | 2024-2025 | Ha Minuteman G3-R, Liberty Si |
| Boston Scientific Corporation | $1,904.40 | 2023-2024 | Vercise |
| Spr Therapeutics, INC | $649.43 | 2023-2025 | Sprint Pns System |
| Globus Medical, INC. | $235.28 | 2025 | Senza, Omnia |
| Nevro Corp. | $222.72 | 2023-2024 | Senza |
| Saluda Medical Americas, INC. | $163.55 | 2024-2025 | Evoke |
| Nalu Medical, INC. | $161.17 | 2025 | Nalu Neurostimulation System |
| Abbvie INC. | $116.48 | 2023-2025 | |
| Averitas Pharma INC. | $94.55 | 2025 | Qutenza |
| Bioventus LLC | $92.75 | 2025 | Durolane, Gelsyn-3 |
| Orthofundamentals, LLC | $84.00 | 2025 | Trellis Si Joint Fusion System |
| Biotronik Nro, INC. | $52.50 | 2023-2024 | Prospera, Biotronik |
| Si-Bone, INC. | $48.92 | 2025 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fidia Pharma USA INC. | $44.70 | 2025 | Hyalgan |
| Relievant Medsystems, INC. | $39.99 | 2023 | Intracept |
| Vertos Medical, INC. | $33.33 | 2023 | Mild Device Kit |
| Painteq LLC | $24.60 | 2024 | Painteq |
| Protega Pharmaceutials INC | $23.70 | 2025 | Roxybond |
| Ipsen Biopharmaceuticals, INC | $22.68 | 2023 | Dysport |
| Azurity Pharmaceuticals, INC. | $22.17 | 2024 | Horizant |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Mousselli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.